BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8803907)

  • 1. Antimalarials in Sjögren's syndrome--the Greek experience.
    Manoussakis MN; Moutsopoulos HM
    Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The geoepidemiology of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Autoimmun Rev; 2010 Mar; 9(5):A305-10. PubMed ID: 19903539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
    Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and management of Sjögren's syndrome: strategies for the advanced practice nurse.
    Vale DL
    Nurs Clin North Am; 2000 Mar; 35(1):267-78. PubMed ID: 10673580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of Epstein-Barr virus in Sjögren's syndrome.
    Fox RI; Chilton T; Scott S; Benton L; Howell FV; Vaughan JH
    Rheum Dis Clin North Am; 1987 Aug; 13(2):275-92. PubMed ID: 2827246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's Syndrome.
    Papiris SA; Tsonis IA; Moutsopoulos HM
    Semin Respir Crit Care Med; 2007 Aug; 28(4):459-71. PubMed ID: 17764063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjogren's syndrome and autoimmune cytopenias: a relation often overlooked.
    Khattri S; Barland P
    Bull NYU Hosp Jt Dis; 2012; 70(2):130-2. PubMed ID: 22892005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Puéchal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J
    Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome.
    Delaleu N; Jonsson R; Koller MM
    Eur J Oral Sci; 2005 Apr; 113(2):101-13. PubMed ID: 15819815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary Sjögren's syndrome with hydroxychloroquine.
    Fox RI; Chan E; Benton L; Fong S; Friedlaender M; Howell FV
    Am J Med; 1988 Oct; 85(4A):62-7. PubMed ID: 3177432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.